The plan, a top priority for Democrats this year, would allow the Secretary of Health and Human Services to negotiate the price of up to 250 drugs annually and take reference from data provided by Medicare, Medicaid, and commercial insurance in determining the aggregate cost, according to a legislative summary distributed to lawmakers.